SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 73 filers reported holding SYNDAX PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,486,183 | -17.0% | 117,717 | 0.0% | 0.10% | -15.9% |
| Q4 2022 | $2,995,898 | +175.6% | 117,717 | +108.4% | 0.11% | +162.8% |
| Q2 2022 | $1,087,000 | +10.7% | 56,480 | 0.0% | 0.04% | +26.5% |
| Q1 2022 | $982,000 | +30.4% | 56,480 | -60.6% | 0.03% | +9.7% |
| Q1 2019 | $753,000 | -15.4% | 143,438 | -28.3% | 0.03% | -18.4% |
| Q4 2018 | $890,000 | -44.9% | 200,000 | 0.0% | 0.04% | -35.6% |
| Q3 2018 | $1,616,000 | +15.1% | 200,000 | 0.0% | 0.06% | +11.3% |
| Q2 2018 | $1,404,000 | -50.7% | 200,000 | 0.0% | 0.05% | -52.3% |
| Q1 2018 | $2,846,000 | +62.4% | 200,000 | 0.0% | 0.11% | +63.2% |
| Q4 2017 | $1,752,000 | -25.1% | 200,000 | 0.0% | 0.07% | -19.0% |
| Q3 2017 | $2,340,000 | -16.2% | 200,000 | 0.0% | 0.08% | -19.2% |
| Q2 2017 | $2,794,000 | – | 200,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 956,165 | $20,930,000 | 11.19% |
| Aisling Capital Management LP | 1,025,000 | $22,437,000 | 7.92% |
| FRAZIER MANAGEMENT LLC | 2,772,062 | $60,680,000 | 4.67% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,176,585 | $25,755,000 | 2.83% |
| Paradigm Biocapital Advisors LP | 453,091 | $9,918,000 | 2.83% |
| Ghost Tree Capital, LLC | 300,000 | $6,567,000 | 2.35% |
| Avidity Partners Management LP | 4,823,400 | $105,584,000 | 2.24% |
| Nantahala Capital Management | 2,850,559 | $62,399,000 | 2.20% |
| ACUTA CAPITAL PARTNERS, LLC | 206,126 | $4,512,000 | 1.90% |
| BVF INC/IL | 2,099,714 | $45,963,000 | 1.67% |